The winners of the 2018 PharmaTimes Clinical Researcher of the Year competition were announced at an awards ceremony and gala dinner last night. It followed a day of fierce competition at the Regency Hyatt, in which 55 individual finalists and 16 teams battled it out for the coveted pharma in each of their respective categories.
US regulators are undertaking a priority review of Sanofi and Regeneron’s cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC), or those with locally advanced CSCC who are not candidates for surgery.
The PharmaTimes Clinical Researcher of the Year - The Americas awards ceremony & gala dinner will take place in Washington DC on Sunday at the Hyatt Regency Crystal City, presented by UK actor Ryan Philpott, who has a host of TV credits to his name, including the nation's all time favourite, Eastenders.
The countdown is on! With just under three weeks to go until the 2018 PharmaTimes International Clinical Researcher of the Year Awards Ceremony, companies are advised to book now to avoid disappointment.
With rigorous entry and judging standards, the all-new Sales Awards is designed to recognise the very best sales professionals in our industry today, while offering a crucial opportunity for learning and development.
Research led by University College London (UCL) and the University of Leeds, with support from a Cancer Research UK/Bupa Foundation Innovation Award, has revealed widespread public belief in “mythical causes” of cancer.
NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T-cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a ‘ground-breaking’ approach to treating cancer.